| PEB0252 | Use of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) beyond the presence of the M184V mutation | E-poster | B35 |
| PEC0468 | Use and willingness to use preexposure prophylaxis for HIV among men who have sex with men | E-poster | C14 |
| PEE1451 | USAID's HIV local partner transition: The Journey to Self Reliance in the era of the sustainable HIV response | E-poster | E24 |
| PEC0564 | USAID HIV/AIDS flagship project: Improving quality and expanding HIV testing and ART treatment for hard-to-reach key populations in Myanmar | E-poster | C33 |
| PEB0127 | Urinary exosome-derived micro-RNAs as biomarkers for tenofovir disoproxil fumarate-associated (TDF) renal toxicity in HIV-1-infected patients | E-poster | B9 |
| PEE1394 | Uptake, yield and linkage to care after home-based HIV counselling and testing among household contacts of tuberculosis patients in Uganda | E-poster | E18 |
| PEE1605 | Uptake of the DREAMS intervention package for HIV prevention among girls in early adolescence: Findings from an impact evaluation in urban Kenya | E-poster | E38 |
| PEC0603 | Uptake of primary care significantly associated with PrEP retention in a mid-sized U.S. city | E-poster | C35 |
| OAC0803 | Uptake of pre-exposure prophylaxis among adolescent girls and young women in PEPFAR-supported countries, 2017-2019 | Oral abstract session with live Q&A | C36 |
| PEC0580 | Uptake of HIV testing among adolescents and young people attending peer-led community-based sexual and reproductive health services in Lusaka, Zambia: Early results from the 'Yathu Yathu' trial | E-poster | C34 |